Morehouse Total Cancer Care Protocol
Trial statusRecruiting
Trial phaseNot listed
Trial typeObservational
Biological sexAll
Age18+
SponsorMorehouse School of Medicine
About this trial
The overall objective of the Morehouse Total Cancer Care study is to develop an improved standard of cancer care by facilitating new biomarker and drug target discovery, informatics solutions, clinical trials, and "personalized medicine" for our community oncology partners (i.e., community hospital systems, and other cancer care providers). To bring new translational research to the community, Morehouse School of Medicine has initiated the Total Cancer Care Program (TCCP). The TCCP establishes a unique collection of blood, tissue, other biological samples and their associated data (survey data, medical records data, cancer registry data, and other related data) from thousands of African American cancer patients, survivors, or those at risk of having cancer. This is not a treatment trial, but a longitudinal study designed to create a centralized cancer biorepository for precision medicine.
Eligibility criteria
This trial accepts healthy volunteersQualifiers
18 years of age and older.
Diagnosed with cancer, or at risk for cancer. This includes anyone in the general population, but our primary focus will be on patients with a cancer diagnosis.
Able to understand and sign the TCCP Informed Consent and Research Authorization form directly or through an authorized representative. The Informed Consent and Research Authorization will be available in both English and Spanish languages
Disqualifiers
None
Trial population
Patients 18 years of age or older who have cancer or are at risk of developing cancer.
Trial design
Design model
Other
Time perspective
Prospective
Treatments tested in this trial
Collection of blood, tissue, and other biological samples.
Procedure/SurgeryBehavioral health assessments, including quality of life.
Medical Chart Review
Other interventionHealth data abstracted directly from patient's health records
Treatment groups
5,000 Participants
are divided into 1 treatment groupGroup A: Biospeciman Repository and Data Collection2 interventions
Trial outcomes
Primary outcomes
1
Improve Standard of Cancer Care
Establish a longitudinal clinical and related data and tissue repository that will contain cancer predisposing risk factors via surveys and questionnaires.
Time frame
Time Frame: up to 20 years2
Improve Standard of Cancer Care
Establish a longitudinal clinical and related data repository that will contain quality of life care via surveys and questionnaires
Time frame
Time Frame: up to 20 years3
Improve Standard of Cancer Care
Establish a longitudinal tissue repository that will contain blood, tissue, and other biological samples other biological samples and associated clinical data collected from consenting patients.
Time frame
Time Frame: up to 20 yearsSponsors and contacts
Click on the lead sponsor to view all of their trials.
Source ClinicalTrials.gov